10x Genomics (TXG) Gross Margin (2018 - 2025)
Historic Gross Margin for 10x Genomics (TXG) over the last 8 years, with Q4 2025 value amounting to 68.09%.
- 10x Genomics' Gross Margin rose 8500.0% to 68.09% in Q4 2025 from the same period last year, while for Dec 2025 it was 69.05%, marking a year-over-year increase of 11900.0%. This contributed to the annual value of 69.05% for FY2025, which is 11900.0% up from last year.
- Per 10x Genomics' latest filing, its Gross Margin stood at 68.09% for Q4 2025, which was up 8500.0% from 67.32% recorded in Q3 2025.
- 10x Genomics' 5-year Gross Margin high stood at 95.76% for Q2 2021, and its period low was 62.18% during Q3 2023.
- Over the past 5 years, 10x Genomics' median Gross Margin value was 71.25% (recorded in 2025), while the average stood at 73.05%.
- Its Gross Margin has fluctuated over the past 5 years, first surged by 191900bps in 2021, then plummeted by -199300bps in 2022.
- 10x Genomics' Gross Margin (Quarter) stood at 80.77% in 2021, then decreased by -5bps to 76.43% in 2022, then decreased by -18bps to 62.93% in 2023, then grew by 7bps to 67.24% in 2024, then grew by 1bps to 68.09% in 2025.
- Its last three reported values are 68.09% in Q4 2025, 67.32% for Q3 2025, and 72.34% during Q2 2025.